Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04558619 · ClinicalTrials.gov registry record · NA

Exploring the Feasibility of Kōmmour Prenatal to Reduce Maternal and Infant Health Disparities

A NA study of Kōmmour Prenatal Among Marshallese Pregnant Women, sponsored by University of Arkansas.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT04558619 is a NA study of Kōmmour Prenatal Among Marshallese Pregnant Women that is actively recruiting participants, run by University of Arkansas. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04558619, a NA study of Kōmmour Prenatal Among Marshallese Pregnant Women, is actively recruiting participants, sponsored by University of Arkansas.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to culturally adapt and examine the feasibility of a group prenatal program (Kōmmour Prenatal) to reduce maternal and infant health disparities among Marshallese Pacific Islander women in the US. The study will also gather information from providers of Kōmmour Prenatal and stakeholders in the Marshallese community familiar with the program to learn of their experience with the program.

Interventions

  • BEHAVIORAL Kōmmour Prenatal

Study Locations (1)

Arkansas

  • University of Arkansas for Medical Sciences Northwest - Fayetteville

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-04-05
Est. Completion 2026-04-01
Phase NA

Sponsor

University of Arkansas

318 total trials

What the Registry Record Tells You About NCT04558619

The ClinicalTrials.gov registry entry for NCT04558619 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Kōmmour Prenatal Among Marshallese Pregnant Women appearing as the primary indexed condition, and to 1 intervention - of which Kōmmour Prenatal is the first listed.

NCT04558619 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.

Frequently Asked Questions

What is clinical trial NCT04558619 about?

NCT04558619 is a clinical study titled "Exploring the Feasibility of Kōmmour Prenatal to Reduce Maternal and Infant Health Disparities". The purpose of the study is to culturally adapt and examine the feasibility of a group prenatal program (Kōmmour Prenatal) to reduce maternal and infant health disparities among Marshallese Pacific Islander women in the US. The study will also gather information from providers of Kōmmour Prenatal an...

What is the current status of trial NCT04558619?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2022-04-05. Estimated completion is 2026-04-01.

What conditions does trial NCT04558619 study?

This clinical trial studies the following conditions: Kōmmour Prenatal Among Marshallese Pregnant Women.

What interventions are being tested in trial NCT04558619?

The interventions under investigation include: Kōmmour Prenatal (BEHAVIORAL).

Who is sponsoring clinical trial NCT04558619?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04558619 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.